NCT03231085View on ClinicalTrials.gov

Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

April 11, 2024

Study Completion Date

October 3, 2024

Conditions

Craniosynostosis

Interventions

DRUG

Ferrous fumarate or ferrostrane

Young children operated with craniosynostosis and treated with EPO and ferrous fumarate or ferostrane per os or intravenous ferric carboxymaltose.

Trial Locations (2)

34295

University Hospital of Montpellier, Montpellier

49100

University Hospital of Angers, Angers

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER

NCT03231085 - Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child | Biotech Hunter | Biotech Hunter